Leishmania Parasites: Classification, Biological Characteristics, Transmission Dynamics, and Clinical Manifestations
DOI:
https://doi.org/10.61952/jlabw.v2i4.665Keywords:
Leishmania parasites, Phlebotomine sandfly, Cutaneous leishmaniasis, Visceral leishmaniasis, Mucocutaneous leishmaniasis, Promastigote, AmastigoteAbstract
Leishmania parasites are obligate intracellular protozoa belonging to the family Trypanosomatidae and represent the primary causative agents of leishmaniasis, a group of neglected tropical diseases (NTDs) that pose substantial morbidity and mortality burdens globally. Transmitted to mammalian hosts via the infectious bites of female phlebotomine sandflies, these parasites exhibit extensive phylogenetic and clinical diversity, giving rise to three major clinical spectrums: Cutaneous Leishmaniasis (CL), Visceral Leishmaniasis (VL or Kala-azar), and Mucocutaneous Leishmaniasis (MCL). The complex digenetic life cycle alternates between extracellular flagellated promastigotes within the insect vector's alimentary tract and intracellular non-motile amastigotes residing within host mononuclear phagocytes.
The transmission dynamics, geographical endemicity, and resurgence of leishmaniasis are heavily modulated by intersecting environmental, bioclimatic, and socioeconomic determinants, including urbanization, poverty, malnutrition, substandard housing, and vector-reservoir ecology. In endemic foci such as North Africa and Libya (notably Sirte, Al-Washka, Abu Qurayn, and northwestern regions), disease management faces critical bottlenecks owing to fragile healthcare infrastructure, under-resourced vector surveillance, and limited diagnostic access.
This review paper provides an in-depth academic synthesis of Leishmania taxonomy, morphology, cellular pathogenesis, immunomodulatory survival mechanisms, and vector-reservoir host relationships. It critically evaluates current direct parasitological, serological, and advanced molecular diagnostic modalities (PCR, rK39, loop-mediated isothermal amplification) and outlines evidence-based therapeutic, vector control, and reservoir management frameworks to mitigate transmission in endemic and resurgent settings.
References
Alvar, J., Vélez, I. D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., & den Boer, M. (2012). Leishmaniasis worldwide and global estimates of its incidence. PLOS ONE, 7(5), e35671. https://doi.org/10.1371/journal.pone.0035671
Bates, P. A. (2007). Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies. International Journal for Parasitology, 37(10), 1097–1106. https://doi.org/10.1016/j.ijpara.2007.04.003
Centers for Disease Control and Prevention. (2024). Parasites - Leishmaniasis: Epidemiology, clinical manifestations, and diagnosis. U.S. Department of Health and Human Services. https://www.cdc.gov/parasites/leishmaniasis/
Desjeux, P. (2001). The increase in risk factors for leishmaniasis worldwide. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95(3), 239–243. https://doi.org/10.1016/S0035-9203(01)90223-8
Katz, M., Despommier, D. D., & Gwadz, R. W. (2020). Parasitic diseases (7th ed.). Parasites Without Borders.
Kaye, P., & Scott, P. (2011). Leishmaniasis: Complexity at the host–pathogen interface. Nature Reviews Microbiology, 9(8), 604–615. https://doi.org/10.1038/nrmicro2608
Khan, M. A., Ullah, S., & Ahmad, I. (2017). Climate change and vector-borne diseases: Impact of temperature and humidity on sandfly abundance. Parasitology Research, 116(4), 1289–1298.
Libyan National Centre for Disease Control [NCDC]. (2023). Annual epidemiological report on vector-borne diseases and cutaneous leishmaniasis in Libyan municipalities. Ministry of Health, State of Libya.
Mann, S., Frasca, K., Scherrer, S., Henao-Martínez, A. F., Newman, S., Ramanan, P., & Suarez, J. A. (2021). A review of leishmaniasis: Current knowledge and future directions. Current Tropical Medicine Reports, 8(2), 121–132. https://doi.org/10.1007/s40475-021-00232-7
Mohapatra, D. P., Panda, S. K., & Dash, R. (2021). Comparative diagnostic accuracy of recombinant antigens in the serodiagnosis of visceral leishmaniasis. Journal of Clinical Microbiology, 59(6), e02114-20. https://doi.org/10.1128/JCM.02114-20
Murray, P. R., Rosenthal, K. S., & Pfaller, M. A. (2020). Medical microbiology (9th ed.). Elsevier.
Santos, G. O., Silva, L. M., & Ferreira, R. C. (2018). Molecular diagnostic advancements in cutaneous and visceral leishmaniasis: A systematic review. Frontiers in Cellular and Infection Microbiology, 8, 305. https://doi.org/10.3389/fcimb.2018.00305
Selvapandiyan, A., Dey, R., & Nakhasi, H. L. (2019). Leishmania parasites: Biology, pathogenesis, and control strategies. Springer Nature.
World Health Organization. (2023). Global leishmaniasis surveillance: 2021–2022 update. Weekly Epidemiological Record, 98(40), 471–488.
World Health Organization. (2024). Leishmaniasis fact sheet (Fact Sheet No. 375). World Health Organization. https://www.who.int/news-room/fact-sheets/detail/leishmaniasis
Mostafa Ramadan Dokhan, Osama Zenbil, Jamal A. Embark, & Badereddin B. Annajar. (2026). Morphological and Morphometric Taxonomic Identification of Phlebotomine Sand Flies (Psychodidae) in Selected Areas of the Al Jabal Al Gharbi Region, Libya. Journal of Libyan Academy Bani Walid, 2(1), 190–207. https://doi.org/10.61952/jlabw.v2i1.442



